Gauging the behaviour of nanoparticles in the lung
Nature Biotechnology
November 8, 2010
The behaviour of nanoparticles in the body after they are deposited in the lungs is reported online in Nature Biotechnology this week. The findings may have implications for future drug delivery, and in the study of air pollution and cancer development.
John Frangioni, Akira Tsuda, and colleagues used near-infrared fluorescent imaging to track nanoparticles administered to the lungs of rats. They varied the chemical composition, size and surface charge of the nanoparticles in order to determine which properties affect the transport of nanoparticles into tissues and their subsequent clearance from the body. The team shows that non-positively charged particles smaller than 34 nanometres in diameter are rapidly transported to lymph nodes, and that nanoparticles smaller than six nanometres with equal positive and negative charge are quickly cleared from the body via the kidneys.
With regard to the health effects of environmental pollutants, this work helps to explain why certain nanoparticles are more toxic than others. It also suggests that the toxicity of nanoparticle pollutants could be reduced by chemical strategies to alter their size and charge.
doi: 10.1038/nbt.1696
Research highlights
-
Jun 24
Palaeontology: It sucked to be the prey of ancient cephalopodsScientific Reports
-
Jun 24
Sport science: New wearable sensor to measure neck strain may detect potential concussionScientific Reports
-
Jun 23
Scientific community: Women credited less than men in scientific paper authorshipNature
-
Jun 17
Conservation: Feral cats pushing critically endangered marsupial further towards extinctionScientific Reports
-
Jun 17
Health technology: New cost-effective smartphone test for middle ear functionCommunications Medicine
-
Jun 16
Microbiology: DNA analysis indicates origins of the Black DeathNature